$CBIS The Company has received a considerable increase in activity from its recent collaboration research agreement with Dana-Farber to research cannabis-based cancer treatments and multiple leadership speaking engagements at Harvard Medical School. The anticipated 25 Million in new funding will allow Cannabis Science to jump-start its aggressive Drug Development programs with its extensive cannabinoid formulation base targeting multiple critical ailments.

http://www.marketwired.com/press-release/cann...208537.htm